Muzika 20mg/37.5mg Tablet
By Muzika
Rx
10 Tablet in a Strip

Composition
Isosorbide Dinitrate(20mg) + Hydralazine(37.5mg)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
February, 2027

liver
Muzika 20mg/37.5mg Tablet seems to be safe for individuals with liver disease based on the available data. It is indicated that adjusting the dosage of Muzika 20mg/37.5mg Tablet may not be necessary for patients with liver conditions. However, as a precaution, it is always advisable to consult with your doctor regarding the use of this medication, especially if you have liver issues. Your doctor will be able to provide you with personalized guidance and ensure that Muzika 20mg/37.5mg Tablet is suitable for you.

kidney
Caution Muzika 20mg/37.5mg Tablet should be used carefully in patients with severe kidney disease. Dose adjustment may be necessary, so consult your doctor. Regular blood pressure monitoring is advised for proper dose management.

alcohol
When using Muzika 20mg/37.5mg Tablet, avoid drinking alcohol as it can lead to unpleasant symptoms like flushing, rapid heartbeat, nausea, thirst, chest pain, and low blood pressure (Disulfiram reaction).

driving
Muzika 20mg/37.5mg Tablet may cause side effects like headaches or difficulty concentrating, affecting driving ability.

pregnancy
Muzika 20mg/37.5mg Tablet may not be safe to use during pregnancy. Studies on animals have shown possible harm to the baby. Your doctor will consider both the benefits and risks before prescribing it to you. Consult your doctor for more information.

breastfeeding
Muzika 20mg/37.5mg Tablet is considered safe during breastfeeding based on limited human data. It is unlikely to pose a significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹86.5
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024